$31.88
-0.76 (-2.33%)
Open$33.43
Previous Close$32.64
Day High$33.75
Day Low$31.69
52W High$37.83
52W Low$11.39
Volume—
Avg Volume385.5K
Market Cap364.36M
P/E Ratio—
EPS$-35.79
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
-75.1% upside
Current
$31.88
$31.88
Target
$7.94
$7.94
$5.53
$7.94 avg
$9.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.64M | 8.63M | 49.01M |
| Net Income | -392,300,607 | -540,855,616 | -2,802,997 |
| Profit Margin | -6,960.8% | -6,612.7% | -5.7% |
| EBITDA | -67,356,951 | -98,022,523 | -4,562,575 |
| Free Cash Flow | — | — | -4,055,082 |
| Rev Growth | -34.7% | -34.7% | +7.4% |
| Debt/Equity | — | — | 0.82 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |